News
Egret Therapeutics Announces the Addition of Three New Members to its Scientific Advisory Board
NEW YORK, Jan. 3, 2023 /PRNewswire/ — Egret Therapeutics, a clinical-stage company focused on the treatment of neurological diseases, today announced the expansion of its Scientific Advisory...
Egret Therapeutics completes oversubscribed pre-A financing round
NEW YORK, Feb. 15, 2022 /PRNewswire/ — Egret Therapeutics, a clinical-stage biotherapeutics company focused on the treatment of neurological diseases, announced today the completion of its pre-A financing....
